Tenon Medical Inc

For the period ended Sep 30, 2024. Filed Nov 14, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 14, 2024

TNON$1.75+6.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 6. Exhibits

EXHIBIT INDEX

Exhibit Number	Description
4.1#	Certificate of Designations, filed in Delaware on September 5, 2024.
4.2#	Amendment to Certificate of Designations, filed in Delaware on September 5, 2024.
10.1##	Offer Letter dated as of August 16, 2024, issued by the Company to Kevin Williamson.
10.2#	Form of Securities Purchase Agreement.
10.3#	Form of Warrant.
10.4###	Form of Series A Warrant.
10.5###	Form of Series B Warrant.
10.6###	Inducement Letter, dated September 16, 2024.
10.7###	Financial Advisory Agreement, dated September 16, 2024.
10.8####	Form of Placement Agency Agreement.
10.9####	Form of Securities Purchase Agreement.
10.10####	Form of Pre-Funded Warrant.
10.11####	Form of Common Warrant.
31.1*	Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer and President of Tenon Medical, Inc.
31.2*	Rule 13a-14(a)/15d-14(a) Certification of the Principal Accounting Officer of Tenon Medical, Inc.
32.1**	Section 1350 Certification of the President and Chief Executive Officer of Tenon Medical, Inc.
32.2**	Section 1350 Certification of the Principal Accounting Officer of Tenon Medical, Inc.
101.INS*	Inline XBRL Instance Document
101.SCH*	Inline XBRL Taxonomy Extension Schema Document
101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

#	Incorporated by reference in the Company’s Current Report on Form 8-K/A filed with the Securities and Exchange Commission on September 10, 2024.

##	Incorporated by reference in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 27, 2024.

###	Incorporated by reference in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 16, 2024.

####	Incorporated by reference in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 17, 2024.

Filed herewith.

Exhibits 32.1 and 32.2 are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.